Status:

COMPLETED

Predicting CSA-AKI With ACTA-PORT Score

Lead Sponsor:

Ankara City Hospital Bilkent

Conditions:

Cardiac Disease

Blood Transfusion

Eligibility:

All Genders

18+ years

Brief Summary

In the scope of this study, it will be determined whether the ACTA-PORT (Association of Cardiothoracic Anesthetists perioperative risk of blood transfusion) scoring system can predict the incidence of...

Detailed Description

ACTA-PORT (Association of Cardiothoracic Anesthetists perioperative risk of blood transfusion) score is a simple, reliable, and validated tool used to predict the risk of transfusion in patients under...

Eligibility Criteria

Inclusion

  • Patients over 18 years old
  • Patients having open heart surgery
  • Patients undergoing surgery by using cardiopulmonary bypass pump

Exclusion

  • Patients under 18 years old
  • Patients diagnosed with kidney disease

Key Trial Info

Start Date :

July 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2024

Estimated Enrollment :

467 Patients enrolled

Trial Details

Trial ID

NCT06484907

Start Date

July 1 2024

End Date

December 1 2024

Last Update

June 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ankara Bilkent City Hospital

Ankara, Ankara, Turkey (Türkiye), 06800

Predicting CSA-AKI With ACTA-PORT Score | DecenTrialz